Skip to content
Bored Studies
RecruitingAccepts healthy volunteers

Care of the Urothelial Cancer Patient and Prospective Procurement of Urothelial Cancer Tissue

National Cancer Institute (NCI) · NCT02379429

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 18–120 · All sexes
Healthy volunteers
Accepted
Study type
Observational
Target enrollment
500
US sites recruiting
1
Study start
November 10, 2015
Record last updated
October 16, 2026

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

Background

Urothelial cancer is cancer of the bladder, ureter, and urethra. Researchers want to better understand what changes in a person s cells and genes cause this cancer to form. This may help them find new ways to treat it.

Objective

  • To perform DNA sequencing to help researchers learn the differences between normal tissue and tumor tissue. Also, to learn how molecular changes - including gene changes - might help predict the course of disease and how people respond to therapy.

Eligibility

  • Adults age 18 and older who have or are suspected of having urothelial cancer or an inherited disorder that raises their risk of getting bladder cancer.

Design

  • Participants will be screened with a physical exam. Their medical records and tissue samples will be reviewed.
  • Eligible participants will give tissue blocks of their original tumor. The blocks will be put in a tissue bank.
  • Participants medical records may be reviewed.
  • Participants may have a medical history and physical exam.
  • Participants may have blood and urine tests. They may have imaging scans. They may give urine, blood, and saliva samples. These samples may be used in future research.
  • If participants need surgery for their cancer, researchers will keep some of the tissue (both tumor and normal tissue). The tissue may be used in future research.
  • Participants will go back to the Clinical Center in 6 months. They may give saliva, urine, and blood samples. After 6 months, they will be seen by their local doctor for standard post-surgical visits.
  • Participants will be called every 6 months to give health updates.

Conditions: Bladder Cancer; Urinary Tract Cancer; Urothelial Cancer; Healthy Volunteers

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria
  • INCLUSION CRITERIA FOR UROTHELIAL CANCER PARTICIPANTS:
  • Adults (>= 18 years of age) with biopsy-proven or suspected urothelial cancer who require and are willing to undergo diagnostic or therapeutic intervention as part of their diagnosis, standard of care treatment, or follow-up/surveillance for their neoplasm.
  • ECOG performance status of 0-3.
  • Must be willing and able to provide informed consent.

EXCLUSION CRITERIA

  • Subjects who are pregnant.
  • Subjects co-morbidities preclude diagnostic or therapeutic intervention. Co-morbidities include:

--Ongoing treatment for another non-skin malignancy.

  • History of hepatitis B/C or HIV. Patients who are HIV positive are excluded from this study because treatment with immunomodulatory agents for immunosuppressed patients would affect sample analysis and skew the data.

ELIGIBILITY CRITERIA FOR HEALTHY VOLUNTEERS

INCLUSION CRITERIA

-Adults (greater than or equal to 18 years of age) and able to give informed consent.

EXCLUSION CRITERIA

  • Subjects who are pregnant.
  • Diagnosis of cancer requiring treatment other than minor resection of basal cell or squamous cell skin cancers.
  • Heart, lung, kidney disease, or other medical conditions as per Principal Investigator discretion.
  • History of acute or chronic hepatitis B/C or HIV infection. Patients who are HIV positive are excluded from this study because treatment with immunomodulatory agents for immunosuppressed patients would affect sample analysis and skew the data.
  • Healthy volunteers who are family members with germline mutations.

Recruiting US locations

  • National Institutes of Health Clinical Center

    Bethesda, MD 20892

    Site contact: NIH Clinical Center Office of Patient Recruitment (OPR) · 800-411-1222 · ccopr@nih.gov

Study contacts (from the official record)

  • Lidenys C O'Brien Gutierrez · (240) 858-7481 · lidenys.o'brien@nih.gov
  • Raju R Chelluri, M.D. · (240) 858-3700 · raju.chelluri@nih.gov
All healthy volunteers studies in Maryland →
Care of the Urothelial Cancer Patient and Prospective Procurement… (NCT02379429) | Bored Studies